Prism Medico
Ticker >

Prism Medico share price

Prism Medico and Pharmacy Ltd.

BSE: 512217 SECTOR: Finance - Investment  6373   22   1

24.26
-0.02 (-0.08%)
BSE: 23 Apr 03:40 PM

Price Summary

Today's High

₹ 24.97

Today's Low

₹ 24.08

52 Week High

₹ 39.2

52 Week Low

₹ 22.05

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 14.71 Cr.

Advances

₹ 0 Cr.

No. of Shares

0.61 Cr.

P/E

150.12

P/B

0.97

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  25.08

Operating Revenue

₹ 1.27 Cr.

Net Profit

₹ -0.08 Cr.

Promoter Holding

25 %

EPS (TTM)

₹  0.16

Sales Growth

-84.95

ROE

-0.55 %

ROCE

-0.74%

Profit Growth

79.34 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year-84.95%
3 Year-63.85%
5 Year-42.91%

Profit Growth

1 Year79.34%
3 Year-21.74%
5 Year-215.33%

ROE%

1 Year-0.55%
3 Year-1.49%
5 Year-0.4%

ROCE %

1 Year-0.74%
3 Year-2%
5 Year-0.85%

ROA%

-0.554501178877971

PEG Ratio

1.89

PAT Margin (%)

-6.01483857841492

EPS Growth(%)

79.3389739090704

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 25 0
Dec 2023 25 0
Sep 2023 25 0
Jun 2023 25 0
Mar 2023 23.93 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company is trading at 1.14497870217299 times the book value

 Limitations

  • Promoters shareholding is low at 25%.
  • Company has a poor Return on Equity (ROE) track record of -1.48513898605369%.
  • The company a poor ROCE track record of -1.9984087699609% since last 3 years.
  • The company has delivered poor profit growth of -63.8477018194441% over past 3 years
  • The company has delivered poor Operating Income growth of -63.8477018194441% over past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Operating Revenue 0 1.27 0 0.03 2.75
Other Income 0 0 0.02 0.01 0
Interest Expended 0 0 0 0 0
Operating Expenses 0.02 1.25 0.1 0.1 2.55
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0 0
Profit Before Tax -0.03 0.03 -0.09 -0.05 0.19
Tax 0 -0.03 0 0 0
Net Profit -0.03 0.05 -0.09 -0.06 0.19
Adjusted EPS (RS) -0.04 0.08 -0.15 -0.09 0.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Operating Income 36.31 26.89 16.76 8.44 1.27
Other Income 0.22 0 0 0 0
Interest 0 0 0 0 0
Operating Expenses 36.23 26.96 16.93 8.94 1.3
Total Provisions 0 0 0 0 0.07
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.29 -0.07 -0.18 -0.5 -0.1
Tax -0.08 -0.02 -0.05 -0.13 -0.03
Profit After Tax 0.37 -0.05 -0.13 -0.37 -0.08
Adjusted EPS (Rs.) 0.61 -0.08 -0.21 -0.61 -0.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.06 6.06 6.06 6.06 6.06
Total Reserves 7.09 6.99 6.86 6.49 9.1
Borrowings 0 0 0 0 0
Other N/C liabilities 0 -0.01 -0.06 -0.19 -0.21
Current liabilities 3.82 8.53 8.62 0.02 0.23
Total Liabilities 16.97 21.57 21.48 12.38 15.18
Assets
Loans 0 0 0 0 0
Net Block 0.09 0.07 0.06 0.05 0.04
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 10 1.94 1.94 0 0
Other Loans 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 6.89 19.56 19.49 12.34 15.14
Total Assets 16.97 21.57 21.48 12.38 15.18
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 23.93 25.00 25.00 25.00 25.00
galaxy vitacare private l... - 8.62 8.62 8.62 8.62
ramit walia - 2.33 2.39 2.39 2.39
symbiosis pharmaceutical ... - 13.99 13.99 13.99 13.99
charanjit singh bhatia 0.06 0.06 - - -
ajooni biotech limited 15.23 - - - -
jasjot singh 3.76 - - - -
parmjeet kaur 4.88 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 76.07 75.00 75.00 75.00 75.00
anil kumar - - 2.58 2.82 2.20
anilkumar . 2.86 4.72 4.72 4.72 4.77
anshul jajoo 1.16 1.16 1.16 1.16 1.04
llp 1.15 1.15 1.15 1.40 0.41
miral hemantbhai bhoot 2.31 1.63 1.63 1.63 1.63
p mukesh kumar 1.86 1.86 1.86 1.86 1.86
prakash chand chaganlal 1.15 1.15 1.15 1.15 1.15
rainbow securities privat... - - - 1.14 1.14
shresth hanuman kanodia 1.58 1.58 1.58 1.48 1.31
upasana rishi parekh - - 1.17 1.17 1.17
vinita jain - - - - 1.59
rainbow traders private l... 1.14 1.14 1.14 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Prism Medico - Quaterly Results13 Feb 2024, 4:20PM Prism Medico And Pharmacy informs about board meeting 1 Nov 2023, 3:14PM Prism Medico And Pharmacy informs about disclosure 19 Jun 2023, 12:15PM Prism Medico and Pharmacy informs about disclosure 25 May 2023, 12:26PM Prism Medico And Pharmacy informs about disclosure 25 May 2023, 10:16AM Prism Medico And Pharmacy informs about press release20 Feb 2023, 3:03PM Prism Medico And Pharmacy informs about updates17 Feb 2023, 3:06PM Prism Medico And Pharmacy informs about compliance certificate15 Oct 2022, 12:08PM Prism Medico And Pharmacy informs about proceedings of AGM 1 Oct 2022, 1:24PM Prism Medico - Quaterly Results25 May 2022, 3:59PM Prism Medico - Quaterly Results25 May 2022, 3:59PM Prism Medico - Quaterly Results25 May 2022, 3:59PM Prism Medico And Pharmacy informs about disclosure26 Apr 2022, 2:34PM Prism Medico - Quaterly Results1 Feb 2022, 4:37PM Prism Medico - Quaterly Results1 Feb 2022, 4:37PM Prism Medico - Quaterly Results1 Feb 2022, 4:37PM Prism Medico And Pharmacy informs about press release6 Jan 2022, 4:36PM Prism Medico And Pharmacy informs about disclosure27 Aug 2021, 1:59PM Prism Medico and Pharmacy informs about notice of 19th AGM25 Aug 2021, 1:47PM Prism Medico And Pharmacy informs about outcome of board meeting20 Aug 2021, 3:25PM Prism Medico and pharmacy informs about disclosure19 Aug 2021, 4:06PM Prism Medico and Pharmacy informs about disclosure24 Jul 2021, 10:14AM Prism Medico & Pharmacy informs about board meeting12 Jul 2021, 12:01PM Prism Medico and Pharmacy informs about disclosure4 Jun 2021, 5:22PM Prism Medico and Pharmacy informs about non-applicability of secretarial compliance report2 Jun 2021, 2:34PM Prism Medico and Pharmacy informs about disclosure26 May 2021, 12:28PM Prism Medico and Pharmacy informs about audited financial results27 Apr 2021, 3:15PM Prism Medico and Pharmacy submits compliance certificate 22 Apr 2021, 12:33PM Prism Medico and Pharmacy informs about resignation of director11 Nov 2020, 4:37PM Prism Medico And Pharmacy informs about disclosure1 Aug 2020, 4:34PM Prism Medico and Pharmacy informs about website updation22 May 2020, 3:34PM Prism Medico and Pharmacy informs about compliance certificate20 May 2020, 1:15PM

Prism Medico Stock Price Analysis and Quick Research Report. Is Prism Medico an attractive stock to invest in?

 

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

To understand the functions of the Prism Medico better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of Prism Medico is Rs -0.0764209 Cr and the compounded growth of profit in the past 3 years is -21.739159436812 %. The PAT margin of Prism Medico is -6.01483857841492 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Prism Medico , the EPS grew by 79.344262295082 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): Prism Medico has a poor ROE track record. The ROE of Prism Medico is at -0.5514506826458 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Prism Medico is worth at the current levels at Rs 24.26. Prism Medico is trading at a current P/E ratio of 0 and the average historical P/E for the last 5 years was 12.1450845232234.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Prism Medico is trading at a P/B of 0.9672 . The average historical P/B for the last 5 years was 0.868725849288449. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

  • Share Price: - The current share price of Prism Medico is Rs 24.26. One can use valuation calculators of ticker to know if Prism Medico share price is undervalued or overvalued.

Last Updated on:
Brief about Prism Medico
X